Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer’s disease therapy - Archive ouverte HAL Access content directly
Journal Articles Journal of Enzyme Inhibition and Medicinal Chemistry Year : 2019

Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer’s disease therapy

, , , , , , , , , , , (1)
1
Irene Pachón-Angona
  • Function : Author
Bernard Refouvelet
  • Function : Author
Rudolf Andrýs
  • Function : Author
Helène Martin
  • Function : Author
Vincent Luzet
  • Function : Author
Isabel Iriepa
Ignacio Moraleda
Daniel Diez-Iriepa
  • Function : Author
María-Jesús Oset-Gasque
  • Function : Author
José Marco-Contelles
Kamil Musilek

Dates and versions

hal-03654661 , version 1 (28-04-2022)

Identifiers

Cite

Irene Pachón-Angona, Bernard Refouvelet, Rudolf Andrýs, Helène Martin, Vincent Luzet, et al.. Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer’s disease therapy. Journal of Enzyme Inhibition and Medicinal Chemistry, 2019, 34 (1), pp.479-489. ⟨10.1080/14756366.2018.1545766⟩. ⟨hal-03654661⟩

Collections

UNIV-FCOMTE
8 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More